ABG Analytics logo
Get updates

Gilead Sciences Inc (NASDAQ: GILD)

DRUGS - Biotechnology
Sector: Health Care
Stock price data as of 09/25/2020
Closing price: 62.25
Support price level: N/A
Resistance price level: $69.05
Relative strength index (14-day RSI) 30.5
Beta 0.07
  • GILD is at or near its 52-week low. Though contrarian gains may be possible, the risk of further declines is considerable.

  • The price of this low-beta stock is expected to increase by 0.07% for every 1% increase in the S&P-500.

  • Volatility is forecast to rise over the next month.

  • Price broke below prior support level - a short-term bearish signal.

Low High Price as % of Range
$61.62 $84.00 3.3%
200 day 50 day 20 day 10 day
$71.45 $68.21 $64.90 $64.35
(Annualized standard deviation)
Historical
(5 year)
Last month Current estimate Next month forecast
28.9% 23.4% 22.7% 28.0%
There is an estimated 5% probability that the stock price of Gilead Sciences Inc will fall by more than:
  • 6.2% in the next week.

  • 15.8% in the next month.

  • 62.7% in the next year.